A carregar...
P17.63 COMBINATION THERAPY WITH TEMOZOLOMIDE, INTERFERON-BETA, AND RIBAVIRIN IN GLIOMA CELL LINES
INTRODUCTION: Although Temozolomide (TMZ) with radiotherapy significantly improves the survival of newly diagnosed glioblastoma although most patients develop tumor progression within 1-2 years. The Japan Clinical Oncology Group (JCOG) are ongoing a phase II randomized study to evaluate the clinical...
Na minha lista:
| Main Authors: | , , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Oxford University Press
2014
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4185763/ https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nou174.392 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|